Cargando…

Molecular Markers of Sulfadoxine-Pyrimethamine Resistance in Samples from Children with Uncomplicated Plasmodium falciparum at Three Sites in Angola in 2019

Sulfadoxine-pyrimethamine (SP) is used for prevention of malaria in pregnant women in Angola. We sequenced the Plasmodium falciparum dihydrofolate reductase (pfdhfr) and dihydropteroate synthase (pfdhps) genes, implicated in SP resistance, in samples collected during a 2019 study of artemisinin-base...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosillo, Stefano R., Dimbu, Pedro Rafael, Cândido, Ana Luisa M., Oh, Je-Hoon Michael, Ferreira, Carolina Miguel, Nieto Andrade, Benjamin, Labuda, Sarah, Horth, Roberta, Kelley, Julia, Morais, Joana F. M., Fortes, Filomeno, Martins, José Franco, Talundzic, Eldin, Pluciński, Mateusz M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Epidemiology and Surveillance
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112138/ https://www.ncbi.nlm.nih.gov/pubmed/36916920 http://dx.doi.org/10.1128/aac.01601-22

Ejemplares similares

Continued Low Efficacy of Artemether-Lumefantrine in Angola in 2019
por: Dimbu, Pedro Rafael, et al.
Publicado: (2021)

Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015
por: Ljolje, Dragan, et al.
Publicado: (2018)

Low-grade sulfadoxine–pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola
por: Kaingona-Daniel, Elsa P. S., et al.
Publicado: (2016)

Efficacy of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015
por: Plucinski, Mateusz M., et al.
Publicado: (2017)

Efficacy and safety of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017
por: Davlantes, Elizabeth, et al.
Publicado: (2018)

Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan
por: Elamin, Sakina B, et al.
Publicado: (2005)

Efficacy of pyrimethamine-sulfadoxine in young children with uncomplicated falciparum malaria in rural Burkina Faso
por: Müller, Olaf, et al.
Publicado: (2004)

Efficacy of Pyrimethamine/Sulfadoxine versus Chloroquine for the Treatment of Uncomplicated Falciparum Malaria in Children Aged Under 5 Years
por: Zheng, W, et al.
Publicado: (2013)

The remarkable tenacity of sulfadoxine-pyrimethamine
por: Divala, Titus H, et al.
Publicado: (2019)

Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola
por: Fortes, Filomeno, et al.
Publicado: (2011)

Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania
por: Kavishe, Reginald A., et al.
Publicado: (2016)

Molecular Markers for Sulfadoxine/Pyrimethamine and Chloroquine Resistance in Plasmodium falciparum in Thailand
por: Kuesap, Jiraporn, et al.
Publicado: (2022)

Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum
por: Brock, Aleisha R., et al.
Publicado: (2017)

Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia
por: Lederman, Edith R, et al.
Publicado: (2006)

Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi
por: Ravenhall, Matt, et al.
Publicado: (2016)

Prevalence of molecular markers of sulfadoxine–pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan
por: Yaqoob, Adnan, et al.
Publicado: (2018)

Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in Africa: a systematic analysis of national trends
por: Amimo, Floriano, et al.
Publicado: (2020)

Origins and spread of novel genetic variants of sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates in Indonesia
por: Basuki, Sukmawati, et al.
Publicado: (2018)

Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali
por: Maiga, Hamma, et al.
Publicado: (2015)

High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania
por: Baraka, Vito, et al.
Publicado: (2015)

Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990–2020
por: Flegg, Jennifer A., et al.
Publicado: (2022)

Population Pharmacokinetic Properties of Sulfadoxine and Pyrimethamine: a Pooled Analysis To Inform Optimal Dosing in African Children with Uncomplicated Malaria
por: de Kock, Miné, et al.
Publicado: (2018)

Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection
por: Plucinski, Mateusz M., et al.
Publicado: (2019)

Assessment of the Teratogenic Effect of Sulfadoxine-Pyrimethamine on the Chicken Embryo
por: Tari, Rachida Moussa, et al.
Publicado: (2022)

Prevention of malaria in pregnancy: The threat of sulfadoxine-pyrimethamine resistance
por: Sundararaman, Sesh A., et al.
Publicado: (2022)

Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine–pyrimethamine in southern Papua, Indonesia
por: Ratcliff, A., et al.
Publicado: (2007)

Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola
por: Foumane Ngane, Vincent, et al.
Publicado: (2015)

Multi-agent modeling and simulation of Plasmodium falciparum dynamics considering sulfadoxine-pyrimethamine resistance and environmental factors
por: Gomez, Daniela Zaffalon, et al.
Publicado: (2014)

Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V
por: Oguike, Mary C., et al.
Publicado: (2016)

Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016–2017
por: Rogier, Eric, et al.
Publicado: (2020)

Evaluating malaria case management at public health facilities in two provinces in Angola
por: Plucinski, Mateusz M., et al.
Publicado: (2017)

High efficacy of two artemisinin-based combinations: artesunate + sulfadoxine-pyrimethamine and artemether-lumefantrine for falciparum malaria in Yemen
por: Adeel, Ahmed A., et al.
Publicado: (2015)

Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
por: Pathak, Ashish, et al.
Publicado: (2020)

Sulfadoxine/Pyrimethamine Intermittent Preventive Treatment for Malaria during Pregnancy
por: Deloron, Philippe, et al.
Publicado: (2010)

Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine–pyrimethamine in Benin
por: Jafari-Guemouri, Sayeh, et al.
Publicado: (2018)

Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria
por: Olowe, Rita A, et al.
Publicado: (2023)

Effect of three years’ seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali
por: Mahamar, Almahamoudou, et al.
Publicado: (2022)

Peripheral and Placental Prevalence of Sulfadoxine–Pyrimethamine Resistance Markers in Plasmodium falciparum among Pregnant Women in Southern Province, Rwanda
por: Alruwaili, Muharib, et al.
Publicado: (2023)

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
por: Awab, Ghulam Rahim, et al.
Publicado: (2016)

Intermittent presumptive treatment in pregnancy with sulfadoxine–pyrimethamine: a counter perspective
por: Nosten, Francois, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_35kvgs8jpou9n79ughu5ne3ggm